AIOBIO CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,250 KRW | +0.31% |
|
-0.76% | -27.54% |
| 2023 | AIOBIO Co., Ltd. announced that it has received KRW 1.000008 billion in funding | CI |
| 2023 | AIOBIO Co., Ltd. announced that it expects to receive KRW 1.000008 billion in funding | CI |
More news
| 1 day | +0.31% | ||
| 1 week | -0.76% | ||
| Current month | +8.33% | ||
| 1 month | +8.33% | ||
| 3 months | +9.06% | ||
| 6 months | -20.34% | ||
| Current year | -27.54% |
1 week
3 200.00
3 260.00
1 month
2 850.003 435.00
Current year
2 350.004 745.00
1 year
2 320.005 340.00
3 years
2 220.008 700.00
5 years
2 220.008 700.00
10 years
2 220.008 700.00
| Managers | Title | Age | Since |
|---|---|---|---|
Hong-Chul Yoon
CEO | Chief Executive Officer | 57 | 10-12-31 |
Hyun-Hoon Jung
BRD | Director/Board Member | 54 | 17-12-31 |
Yeon-Hwa Jang
AUD | Comptroller/Controller/Auditor | 55 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hong-Chul Yoon
CEO | Chief Executive Officer | 57 | 10-12-31 |
Yo-Han Kim
BRD | Director/Board Member | 41 | 16-12-31 |
Hyun-Hoon Jung
BRD | Director/Board Member | 54 | 17-12-31 |
AioBio Co Ltd is a Korea-based company primarily engaged in the manufacture and sale of medical devices. The Company is engaged in the manufacture and sale of medical devices such as dental caries and plaque inspection equipment for dental hospitals and clinics, optical dental caries diagnosis devices. The Company is also engaged in the development and provision of Qray medical image measurement and quantification software.
| 1st Jan change | Capi. | |
|---|---|---|
| -27.54% | 6.05M | |
| -7.76% | 177B | |
| -5.55% | 65.54B | |
| -6.12% | 47.09B | |
| +9.54% | 43.43B | |
| +8.14% | 41.77B | |
| +13.96% | 29.55B | |
| +15.53% | 24.83B | |
| -6.82% | 23.97B | |
| -6.00% | 23.54B |
- Stock Market
- Equities
- A447690 Stock
